Mallinckrodt and Endo to Combine to Create a Global, Scaled . . . Mallinckrodt and Endo plan to combine their generic pharmaceuticals businesses and Endo's sterile injectables business after the close of the transaction and intend to separate that business from the combined company at a later date
Mallinckrodt and Endo Announce Significant Progress in Proposed Merger As announced on March 13, 2025, the proposed Mallinckrodt and Endo transaction envisions the spin-off of the combined generic pharmaceuticals businesses and Endo's sterile injectables business into a new standalone entity separate from the remaining branded pharmaceuticals business
Investors | Endo - Overview Mallinckrodt and Endo have merged to create a global, scaled, diversified therapeutics leader Visit our new Investor Relations website at ir mallinckrodt com for up-to-date investor relations information and subscribe to email alerts
Endo Launches New Peyronies Disease Campaign: I Got Somebody Through this new campaign, Endo is encouraging men to overcome their fear and discuss PD and nonsurgical treatment options so they can be informed and help others by sharing their experiences This shared knowledge helps individuals make informed decisions by leveraging trusted recommendations